Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target Cut to $60.00 by Analysts at Barclays
Tarsus Pharmaceuticals (NASDAQ:TARS – Free Report) had its target price decreased by Barclays from $62.00 to $60.00 in a report released on Wednesday morning,Benzinga reports....
Q1 EPS Estimates for USANA Health Sciences Cut by Sidoti Csr
USANA Health Sciences, Inc. (NYSE:USNA – Free Report) – Stock analysts at Sidoti Csr dropped their Q1 2025 earnings per share estimates for USANA Health...
Needham & Company LLC Reaffirms Hold Rating for PayPal (NASDAQ:PYPL)
Needham & Company LLC restated their hold rating on shares of PayPal (NASDAQ:PYPL – Free Report) in a research report sent to investors on Wednesday...
CAVA Group’s (CAVA) Outperform Rating Reaffirmed at Wedbush
Wedbush restated their outperform rating on shares of CAVA Group (NYSE:CAVA – Free Report) in a research note released on Wednesday morning,Benzinga reports. They currently...
Arcutis Biotherapeutics’ (ARQT) Buy Rating Reiterated at Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) in a research report report published on Wednesday...
Portillo’s (NASDAQ:PTLO) Stock Price Expected to Rise, Stephens Analyst Says
Portillo’s (NASDAQ:PTLO – Free Report) had its price target lifted by Stephens from $13.00 to $14.00 in a report released on Wednesday morning,Benzinga reports. Stephens...